Comments
Loading...

THC Farmaceuticals Analyst Ratings

CBDGOTCPK
Logo brought to you by Benzinga Data
$0.0141
0.0001000.71%
At close: -

THC Farmaceuticals Analyst Ratings and Price Targets | OTC:CBDG | Benzinga

THC Farmaceuticals Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for THC Farmaceuticals Corp from these most-recent analyst ratings.

Analyst Ratings for THC Farmaceuticals

Buy NowGet Alert
No data available to display

FAQ

Q

What is the target price for THC Farmaceuticals (CBDG) stock?

A

There is no price target for THC Farmaceuticals

Q

What is the most recent analyst rating for THC Farmaceuticals (CBDG)?

A

There is no analyst for THC Farmaceuticals

Q

When was the last upgrade for THC Farmaceuticals (CBDG)?

A

There is no last upgrade for THC Farmaceuticals

Q

When was the last downgrade for THC Farmaceuticals (CBDG)?

A

There is no last downgrade for THC Farmaceuticals.

Q

When is the next analyst rating going to be posted or updated for THC Farmaceuticals (CBDG)?

A

There is no next analyst rating for THC Farmaceuticals.

Q

Is the Analyst Rating THC Farmaceuticals (CBDG) correct?

A

There is no next analyst rating for THC Farmaceuticals.

Browse analyst ratings and price targets on all stocks.